Oliver Schon
12Patents
4h-index
30Co-inventors
56Inventor score
Filing activity: Feb 8, 2007 → Mar 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9321832B2 | Ligand | Chemistry; Metallurgy | 9 | Active |
| US8679496B2 | Anti-serum albumin single variable domains | Chemistry; Metallurgy | 5 | Active |
| US9012609B2 | Anti-serum albumin binding variants | Chemistry; Metallurgy | 5 | Active |
| US9175071B2 | Anti-serum albumin binding variants | Chemistry; Metallurgy | 4 | Active |
| US11692042B2 | Anti-CD73 antibodies and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US8236931B2 | Prevention of aggregation of immunoglobulin light or heavy chains | Chemistry; Metallurgy | 1 | Active |
| US9809558B2 | Compounds for affinity chromatography and for extending the half-life of a therapeutic agent | Chemistry; Metallurgy | 0 | Active |
| US9534043B2 | Anti-serum albumin binding variants | Chemistry; Metallurgy | 0 | Active |
| US9751935B2 | Anti-serum albumin binding variants | Chemistry; Metallurgy | 0 | Active |
| US10696738B2 | Anti-serum albumin binding variants | Chemistry; Metallurgy | 0 | Active |
| US9040668B2 | Anti-serum albumin binding variants | Chemistry; Metallurgy | 0 | Active |
| US9938243B2 | Compounds for affinity chromatography and for extending the half-life of a therapeutic agent | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.